When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNDX - Syndax Pharmaceuticals names COO Michael Metzger as CEO
Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals (NASDAQ:SNDX) said Michael Metzger, president and COO, will transition to the role of CEO, effective Feb. 3. Briggs Morrison, CEO, will transition to the role of president, head of R&D. Metzger and Morrison will remain on SNDX's board. "With topline data expected early next year for both of our ongoing SNDX-5613 and axatilimab registration programs, we are keenly focused on preparations for multiple potential New Drug Application filings in 2023," said Morrison.